IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
465.00
-10.07 (-2.12%)
May 6, 2025, 9:38 AM EDT - Market open
IDEXX Laboratories Market Cap
IDEXX Laboratories has a market cap or net worth of $37.40 billion as of May 6, 2025. Its market cap has decreased by -5.89% in one year.
Market Cap
37.40B
Enterprise Value
39.10B
1-Year Change
-5.89%
Ranking
Category
Stock Price
$465.00
Market Cap Chart
Since December 1, 1998, IDEXX Laboratories's market cap has increased from $1.04B to $37.40B, an increase of 3,482.35%. That is a compound annual growth rate of 14.50%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 2, 2025 | 37.95B | 12.10% |
Dec 31, 2024 | 33.85B | -26.56% |
Dec 29, 2023 | 46.10B | 36.44% |
Dec 30, 2022 | 33.79B | -39.49% |
Dec 31, 2021 | 55.83B | 30.94% |
Dec 31, 2020 | 42.64B | 90.35% |
Dec 31, 2019 | 22.40B | 39.64% |
Dec 31, 2018 | 16.04B | 17.61% |
Dec 29, 2017 | 13.64B | 29.72% |
Dec 30, 2016 | 10.51B | 58.51% |
Dec 31, 2015 | 6.63B | -6.18% |
Dec 31, 2014 | 7.07B | 28.08% |
Dec 31, 2013 | 5.52B | 8.80% |
Dec 31, 2012 | 5.07B | 17.41% |
Dec 30, 2011 | 4.32B | 8.56% |
Dec 31, 2010 | 3.98B | 27.10% |
Dec 31, 2009 | 3.13B | 45.74% |
Dec 31, 2008 | 2.15B | -40.14% |
Dec 31, 2007 | 3.59B | 44.63% |
Dec 29, 2006 | 2.48B | 7.57% |
Dec 30, 2005 | 2.31B | 25.59% |
Dec 31, 2004 | 1.84B | 13.89% |
Dec 31, 2003 | 1.61B | 40.86% |
Dec 31, 2002 | 1.15B | 19.54% |
Dec 31, 2001 | 958.00M | 31.13% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 740.90B |
Johnson & Johnson | 373.00B |
UnitedHealth Group | 367.38B |
AbbVie | 347.85B |
Novo Nordisk | 307.48B |
Abbott Laboratories | 229.83B |
Novartis AG | 223.50B |
AstraZeneca | 221.69B |